Surrogate Outcome Measures of In Vitro Osteoclast Resorption of β Tricalcium Phosphate.

about

Spatiotemporally Controlled Release of Rho-Inhibiting C3 Toxin from a Protein-DNA Hybrid Hydrogel for Targeted Inhibition of Osteoclast Formation and Activity.

P2860

Q47863891-DD5CB47C-5F07-446B-8DDF-F4E01321DF03

P2860

Surrogate Outcome Measures of In Vitro Osteoclast Resorption of β Tricalcium Phosphate.

Item

http://www.wikidata.org/entity/Q51083940

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Surrogate Outcome Measures of In Vitro Osteoclast Resorption of β Tricalcium Phosphate.

@en

Surrogate Outcome Measures of In Vitro Osteoclast Resorption of β Tricalcium Phosphate.

@nl

type

Item

label

Surrogate Outcome Measures of In Vitro Osteoclast Resorption of β Tricalcium Phosphate.

@en

Surrogate Outcome Measures of In Vitro Osteoclast Resorption of β Tricalcium Phosphate.

@nl

prefLabel

Surrogate Outcome Measures of In Vitro Osteoclast Resorption of β Tricalcium Phosphate.

@en

Surrogate Outcome Measures of In Vitro Osteoclast Resorption of β Tricalcium Phosphate.

@nl

P1476

Surrogate Outcome Measures of In Vitro Osteoclast Resorption of β Tricalcium Phosphate

@en

P2093

Fraser Buchanan

http://www.w3.org/2001/XMLSchema#string

Joanne Martin

http://www.w3.org/2001/XMLSchema#string

John Nelson

http://www.w3.org/2001/XMLSchema#string

Nicholas Dunne

http://www.w3.org/2001/XMLSchema#string

P2860

NIH Image to ImageJ: 25 years of image analysis

Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification

Characterization of melt-derived 45S5 and sol-gel-derived 58S bioactive glasses.

Complex dynamics of osteoclast formation and death in long-term cultures.

The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro.

Calcium phosphate phases integrated in silica/collagen nanocomposite xerogels enhance the bioactivity and ultimately manipulate the osteoblast/osteoclast ratio in a human co-culture model.

Osteoclastogenesis, bone resorption, and osteoclast-based therapeutics.

Bone repair in the twenty-first century: biology, chemistry or engineering?

Porosity of 3D biomaterial scaffolds and osteogenesis.

Bone substitutes: an update.

P31

scholarly article

P356

10.1002/ADHM.201600947

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marc Bohner

Susan A Clarke

Jean-Christophe Hornez

P577

2016-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27930865

http://www.w3.org/2001/XMLSchema#string

Surrogate Outcome Measures of In Vitro Osteoclast Resorption of β Tricalcium Phosphate.

about

P2860

P2860

Surrogate Outcome Measures of In Vitro Osteoclast Resorption of β Tricalcium Phosphate.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698